All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.

A brand new candidate for weight-loss treatment is on the table, with scientists uncovering for the first time how a hormone ...

Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

An analysis of the gut microbiome in women from four African countries provides crucial data for this under-represented ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

A study of men with a family history of prostate cancer has discovered an inherited form of prostate cancer. The inherited ...

Treatment with the highest dose of investigational injectable amycretin -- a unimolecular GLP-1 and amylin receptor agonist -- yielded a 22% weight loss after 36 weeks in a phase Ib/IIa trial, said ...

People with diabetes and obesity are at higher risk for severe respiratory illness caused by viruses, including serious ...

RFK Jr. is declaring war on chronic illness, which, if he succeeds, will not only make us healthier but will also cut down ...

Versant Ventures continues to invest in the increasingly competitive obesity space, this time launching Helicore with $65 ...